[Anticholinergics and their cardiovascular effects--between fear and reality]

Pneumologia. 2010 Apr-Jun;59(2):107-8.
[Article in Romanian]
No abstract available

MeSH terms

  • Administration, Inhalation
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / mortality
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / adverse effects*
  • Evidence-Based Medicine
  • Heart Failure / chemically induced
  • Humans
  • Ipratropium / administration & dosage
  • Ipratropium / adverse effects*
  • Myocardial Ischemia / chemically induced
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / mortality
  • Risk Factors
  • Scopolamine Derivatives / administration & dosage
  • Scopolamine Derivatives / adverse effects*
  • Smoking / adverse effects
  • Survival Analysis
  • Tiotropium Bromide

Substances

  • Cholinergic Antagonists
  • Scopolamine Derivatives
  • Ipratropium
  • Tiotropium Bromide